MAYZENT 2 mg/1
siponimod · TABLET, FILM COATED · Novartis Pharmaceuticals Corporation
Mayzent (siponimod) is an oral tablet used to treat secondary progressive multiple sclerosis, a progressive form of MS where symptoms gradually worsen over time. It works by modulating sphingosine 1-phosphate receptors to help reduce disease activity and slow progression.
Key Facts
- Brand Name
- MAYZENT
- Generic Name
- siponimod
- NDC Code (Product)
0078-0986- Manufacturer
- Novartis Pharmaceuticals Corporation
- Strength
- 2 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA209884
- Drug Class
- Sphingosine 1-phosphate Receptor Modulator [EPC]
- Marketing Start
- 03/26/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is MAYZENT used for?
Mayzent (siponimod) is an oral tablet used to treat secondary progressive multiple sclerosis, a progressive form of MS where symptoms gradually worsen over time. It works by modulating sphingosine 1-phosphate receptors to help reduce disease activity and slow progression.
Is MAYZENT a controlled substance?
MAYZENT is not classified as a controlled substance by the DEA.
What is the generic name for MAYZENT?
The generic name for MAYZENT is siponimod. There are no other listed brand versions of siponimod.
What is the NDC code for MAYZENT 2 mg/1?
The NDC (National Drug Code) for MAYZENT 2 mg/1 is 0078-0986, listed by Novartis Pharmaceuticals Corporation.
Other MAYZENT Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)